Page 1

COGNITION THERAPEUTICS NASDAQ : CGTX Zervimesine in DLB Psychosis An Investigational Oral Therapy Advancing Toward Registrational Development August 2026 · Investor Presentation COGNITION Therapeutics https://cogrx.com